No Data
No Data
No Data
No Data
No Data
Surmodics Is Maintained at Outperform by Barrington Research
Surmodics Is Maintained at Outperform by Barrington Research
Dow Jones14:35 ET
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and SurModics (SRDX)
TipRanksMay 2 09:20 ET
Express News | Surmodics Inc : Barrington Research Raises Target Price to $71 From $70
ReutersMay 2 09:03 ET
The 28% Return This Week Takes Surmodics' (NASDAQ:SRDX) Shareholders One-year Gains to 45%
Passive investing in index funds can generate returns that roughly match the overall market. But if you pick the right individual stocks, you could make more than that. For example, the Surmodics, I
Simply Wall StMay 2 07:52 ET
Express News | Surmodics Inc : Needham Cuts Target Price to $43 From $47
ReutersMay 2 04:24 ET
Earnings Call Summary | SurModics(SRDX.US) Q2 2024 Earnings Conference
The following is a summary of the Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript:Financial Performance:Surmodics reported Q2 revenue growth of 18% to $32 million, exceeding expectations.Medic
moomoo AIMay 1 23:40 ET · Conference Call
GotLongTerm : Don’t forget about $WiSA Technologies (WISA.US)$ friend.
chris from queens GotLongTerm: if WiSa gets over .15 tomorrow it's gonna go
GotLongTerm chris from queens: I’m loaded up. It may even dwarf $Genius Group (GNS.US)$ . Maybe..
No Data
No Data